Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) have a substantial burden on health-care systems around the world. This is a randomized parallel controlled trial for assessment of the immunogenicity and...
Saved in:
Main Authors: | Yongliang Feng (Author), Jing Chen (Author), Tian Yao (Author), Yue Chang (Author), Xiaoqing Li (Author), Rongqin Xing (Author), Hong Li (Author), Ruixue Xie (Author), Xiaohong Zhang (Author), Zhiyun Wei (Author), Shengcai Mu (Author), Ling Liu (Author), Lizhong Feng (Author), Suping Wang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial
by: Yongliang Feng, et al.
Published: (2017) -
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China
by: Shi-Yuan Wang, et al.
Published: (2017) -
How to Increase the Immunogenicity of SARS-COV-2 Inactivated Vaccines?
by: Yousef Khadivi
Published: (2021) -
Immunogenicity of inactivated rotavirus in rhesus monkey, and assessment of immunologic mechanisms
by: Yan Zhou, et al.
Published: (2023) -
Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
by: Ting Zhao, et al.
Published: (2022)